Funder: National Multiple Sclerosis Society

Due Dates (Anticipated): March 2026 (Pre-application/LOI) | June 2026 (Full application, institutional signatory by 5:00 PM ET)

Funding Amounts: Funding supports research projects translating MS discoveries into commercial products; typical award size and duration vary by project.

Summary: Supports research projects aimed at developing new commercial therapies, technologies, or products for multiple sclerosis.